{"pmid":32301928,"title":"COVID-19, Cancer, and Financial Toxicity.","text":["COVID-19, Cancer, and Financial Toxicity.","When I first started this editorial in early March, I was writing from my usual coffee shop location, and the media was starting to focus on COVID-19. The incidence of the virus was increasing across the world, and the word \"pandemic\"-although debated passionately at the time-was beginning to gain traction. All signs pointed to a disruption; however, the scale of that change has exceeded what most of us could have imagined in early March. Now, millions of Americans and people around the world are in self-isolation, quarantine, or lockdown. There have been roughly 1.4 million cases of COVID-19 and more than 83,000 deaths worldwide at the time of this writing (Johns Hopkins University and Medicine, 2020). Like most, with the exception of essential personnel, I am at home wondering what is going to happen next and trying to find any positive outcome to this crisis.","Oncol Nurs Forum","Lyon, Debra","32301928"],"abstract":["When I first started this editorial in early March, I was writing from my usual coffee shop location, and the media was starting to focus on COVID-19. The incidence of the virus was increasing across the world, and the word \"pandemic\"-although debated passionately at the time-was beginning to gain traction. All signs pointed to a disruption; however, the scale of that change has exceeded what most of us could have imagined in early March. Now, millions of Americans and people around the world are in self-isolation, quarantine, or lockdown. There have been roughly 1.4 million cases of COVID-19 and more than 83,000 deaths worldwide at the time of this writing (Johns Hopkins University and Medicine, 2020). Like most, with the exception of essential personnel, I am at home wondering what is going to happen next and trying to find any positive outcome to this crisis."],"journal":"Oncol Nurs Forum","authors":["Lyon, Debra"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32301928","week":"202016|Apr 13 - Apr 19","doi":"10.1188/20.ONF.253-254","keywords":["caregiving","coronavirus","financial toxicity","treatment decision making","uninsured and underinsured individuals"],"source":"PubMed","weight":0,"locations":["Americans"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664357978653851648,"score":8.233237,"similar":[{"pmid":32239781,"title":"What use are words at a time like this?","text":["What use are words at a time like this?","What use are words at a time like this? I am writing this on 27th March as the world is plunging further into the coronavirus crisis. Like many worldwide, I am in virtual 'lockdown' in Australia while the exponential spread of the virus continues. At a follow-up tele-consult with my medical consultant recently, he said that he was apprehensive about the 'calm before the storm' that our health services face. He was deadly serious.","J Clin Nurs","Darbyshire, Philip","32239781"],"abstract":["What use are words at a time like this? I am writing this on 27th March as the world is plunging further into the coronavirus crisis. Like many worldwide, I am in virtual 'lockdown' in Australia while the exponential spread of the virus continues. At a follow-up tele-consult with my medical consultant recently, he said that he was apprehensive about the 'calm before the storm' that our health services face. He was deadly serious."],"journal":"J Clin Nurs","authors":["Darbyshire, Philip"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239781","week":"202014|Mar 30 - Apr 05","doi":"10.1111/jocn.15273","source":"PubMed","locations":["Australia"],"countries":["Australia"],"countries_codes":["AUS|Australia"],"weight":0,"_version_":1663352135684718592,"score":197.13297},{"pmid":32201354,"pmcid":"PMC7102597","title":"SARS-CoV-2: fear versus data.","text":["SARS-CoV-2: fear versus data.","SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-COV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing.","Int J Antimicrob Agents","Roussel, Yanis","Giraud-Gatineau, Audrey","Jimeno, Marie-Therese","Rolain, Jean-Marc","Zandotti, Christine","Colson, Philippe","Raoult, Didier","32201354"],"abstract":["SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-COV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing."],"journal":"Int J Antimicrob Agents","authors":["Roussel, Yanis","Giraud-Gatineau, Audrey","Jimeno, Marie-Therese","Rolain, Jean-Marc","Zandotti, Christine","Colson, Philippe","Raoult, Didier"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32201354","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.ijantimicag.2020.105947","keywords":["COVID-19","Coronavirus","SARS-CoV-2"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1663352133644189696,"score":171.50519},{"pmid":32170898,"title":"COVID-19 and Rationally Layered Social Distancing.","text":["COVID-19 and Rationally Layered Social Distancing.","I would like to thank Dr. Thomson for the very pertinent and relevant points that he raised in his thoughtful letter Where are we now with COVID-19? [1]. As my response will illustrate, and in what probably will become a defining feature of conversations surrounding COVID-19 for quite some time, attempts to answer will only make room for more questions. As COVID-19 is unfolding, every day is marked by novel developments. Since the editorial went to press [2], the outbreak has expanded considerably. Over 128,000 individuals were infected worldwide as of March 13, 2020, leading to 4720 deaths [3]. In early March, while the outbreak in China appeared to start to subside [4], it started to amplify in Europe and the United States. The first fatality in the United States occurred on February 29, 2020 in a suburb of Seattle. On March 4m the first death was reported outside WA state, in CA, and was the 11(th) death in the United States. On March 6, the first two fatalities were reported in Florida. On March 11, 2020, the World Health Organization declared the outbreak a pandemic [5].","Int J Clin Pract","Stein, Richard","32170898"],"abstract":["I would like to thank Dr. Thomson for the very pertinent and relevant points that he raised in his thoughtful letter Where are we now with COVID-19? [1]. As my response will illustrate, and in what probably will become a defining feature of conversations surrounding COVID-19 for quite some time, attempts to answer will only make room for more questions. As COVID-19 is unfolding, every day is marked by novel developments. Since the editorial went to press [2], the outbreak has expanded considerably. Over 128,000 individuals were infected worldwide as of March 13, 2020, leading to 4720 deaths [3]. In early March, while the outbreak in China appeared to start to subside [4], it started to amplify in Europe and the United States. The first fatality in the United States occurred on February 29, 2020 in a suburb of Seattle. On March 4m the first death was reported outside WA state, in CA, and was the 11(th) death in the United States. On March 6, the first two fatalities were reported in Florida. On March 11, 2020, the World Health Organization declared the outbreak a pandemic [5]."],"journal":"Int J Clin Pract","authors":["Stein, Richard"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32170898","week":"202011|Mar 09 - Mar 15","doi":"10.1111/ijcp.13501","source":"PubMed","locations":["United States","Seattle","China","Florida"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1663352133966102528,"score":159.588},{"pmid":32221976,"title":"Strange Days.","text":["Strange Days.","As people around the globe grapple with the COVID-19 pandemic it is difficult to know what to write in this space. Given publication lags, academic periodicals like Medical Education are a terrible place for \"news\" at the best of times. Our recently started release of \"Accepted Articles\" ensures this editorial will be made public in days rather than months, but the current situation is changing for many of us by the hour. With no capacity to know the future, the only claim I can make with confidence is that things are different now, when you're reading this text, relative to when it was written.","Med Educ","Eva, Kevin W","32221976"],"abstract":["As people around the globe grapple with the COVID-19 pandemic it is difficult to know what to write in this space. Given publication lags, academic periodicals like Medical Education are a terrible place for \"news\" at the best of times. Our recently started release of \"Accepted Articles\" ensures this editorial will be made public in days rather than months, but the current situation is changing for many of us by the hour. With no capacity to know the future, the only claim I can make with confidence is that things are different now, when you're reading this text, relative to when it was written."],"journal":"Med Educ","authors":["Eva, Kevin W"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32221976","week":"202014|Mar 30 - Apr 05","doi":"10.1111/medu.14164","source":"PubMed","weight":0,"_version_":1663352135187693568,"score":152.46446},{"pmid":32269597,"pmcid":"PMC7134578","title":"Upheaval in cancer care during the COVID-19 outbreak.","text":["Upheaval in cancer care during the COVID-19 outbreak.","On Monday, 23 March 2020, Nigeria recorded its first mortality from the novel global COVID-19 outbreak. Before this, the country reported 36 confirmed cases (at the time of writing) and has discharged home two cases after weeks of care at a government-approved isolation centre in Lagos State. This first mortality was that of a 67-year-old man with a history of multiple myeloma, a type of blood cancer. He was undergoing chemotherapy and had just returned to Nigeria following medical treatment in the United Kingdom. The novel COVID-19 pandemic has grounded several global activities including the provision of health care services to people with chronic conditions such as cancer. Evidence from China suggests that cancer patients with COVID-19 infection are a vulnerable group, with a higher risk of severe illness resulting in intensive care unit admissions or death, particularly if they received chemotherapy or surgery. This letter is an attempt to suggest practicable interventions such as the use of existing digital health platforms to limit patients' and oncology professionals' physical interactions as a way of reducing the risk of COVID-19 infection transmission amongst cancer patients and oncologists, as well as outlining effective strategies to ensure that cancer care is not completely disrupted during the outbreak.","Ecancermedicalscience","Salako, Omolola","Okunade, Kehinde","Allsop, Matthew","Habeebu, Muhammedu","Toye, Mariam","Oluyede, Glory","Fagbenro, Gabriel","Salako, Babatunde","32269597"],"abstract":["On Monday, 23 March 2020, Nigeria recorded its first mortality from the novel global COVID-19 outbreak. Before this, the country reported 36 confirmed cases (at the time of writing) and has discharged home two cases after weeks of care at a government-approved isolation centre in Lagos State. This first mortality was that of a 67-year-old man with a history of multiple myeloma, a type of blood cancer. He was undergoing chemotherapy and had just returned to Nigeria following medical treatment in the United Kingdom. The novel COVID-19 pandemic has grounded several global activities including the provision of health care services to people with chronic conditions such as cancer. Evidence from China suggests that cancer patients with COVID-19 infection are a vulnerable group, with a higher risk of severe illness resulting in intensive care unit admissions or death, particularly if they received chemotherapy or surgery. This letter is an attempt to suggest practicable interventions such as the use of existing digital health platforms to limit patients' and oncology professionals' physical interactions as a way of reducing the risk of COVID-19 infection transmission amongst cancer patients and oncologists, as well as outlining effective strategies to ensure that cancer care is not completely disrupted during the outbreak."],"journal":"Ecancermedicalscience","authors":["Salako, Omolola","Okunade, Kehinde","Allsop, Matthew","Habeebu, Muhammedu","Toye, Mariam","Oluyede, Glory","Fagbenro, Gabriel","Salako, Babatunde"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32269597","week":"202015|Apr 06 - Apr 12","doi":"10.3332/ecancer.2020.ed97","keywords":["COVID-19","cancer","cancer treatment","coronavirus"],"source":"PubMed","locations":["Lagos State","Nigeria","China","United Kingdom"],"countries":["Nigeria","United Kingdom","China"],"countries_codes":["NGA|Nigeria","GBR|United Kingdom","CHN|China"],"topics":["Treatment","Prevention"],"weight":1,"_version_":1663620083103039488,"score":152.369}]}